Bicycle Therapeutics plc American Depositary Shares (BCYC) is a publicly traded Healthcare sector company. As of July 30, 2026, BCYC trades at $3.91 with a market cap of $275.06M and a P/E ratio of -1.09. BCYC moved +1.40% today. Year to date, BCYC is -45.48%; over the trailing twelve months it is -54.69%. Its 52-week range spans $3.85 to $21.50. Analyst consensus is buy with an average price target of $10.20. Rallies surfaces BCYC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Bicycle Therapeutics plc American Depositary Shares (BCYC) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. BCYC moved +1.40% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $3.91 |
| Market Cap | $275.06M |
| P/E Ratio | -1.09 |
| EPS | $-3.62 |
| Dividend Yield | 0.00% |
| 52-Week High | $21.50 |
| 52-Week Low | $3.85 |
| Volume | 2.04K |
| Avg Volume | 0 |
| Revenue (TTM) | $28.34M |
| Net Income | $-250.66M |
| Gross Margin | 0.00% |
6 analysts cover BCYC: 0 strong buy, 3 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $10.20.